IVOSX | MVCAX | IVOSX / MVCAX | |
Total Expense Ratio | 0.73 | 0.99 | 74% |
Annual Report Gross Expense Ratio | 0.93 | 1.00 | 93% |
Fund Existence | 11 years | 24 years | - |
Gain YTD | 11.617 | 5.508 | 211% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 907M | 17.3B | 5% |
Annual Yield % from dividends | 1.66 | 0.84 | 199% |
Returns for 1 year | 3.01 | -2.57 | -117% |
Returns for 3 years | 23.21 | 18.36 | 126% |
Returns for 5 years | 49.38 | 52.00 | 95% |
Returns for 10 years | 119.85 | 75.57 | 159% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QCLN | 38.26 | 0.80 | +2.14% |
First Trust NASDAQ® Cln Edge® GrnEngyETF | |||
HBMBF | 219.20 | N/A | N/A |
HBM Bioventures AG | |||
DECT | 34.57 | -0.07 | -0.21% |
AllianzIM U.S. Large Cp Buffer10 Dec ETF | |||
PTLC | 53.09 | -0.16 | -0.30% |
Pacer Trendpilot™ US Large Cap ETF | |||
BCDF | 30.56 | -0.20 | -0.66% |
Horizon Kinetics Blockchain Dev ETF |